MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

27 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 287.90 million declined by -92.13% from Rs. 3658.60 millions.The Net Loss for the quarter ended March 2022 is Rs. -31.10 millions as compared to Net Profit of Rs. 351.60 millions of corresponding quarter ended March 2021Operating profit for the quarter ended March 2022 decreased to 55.10 millions as compared to 689.70 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 287.90 3658.60 -92.13 877.50 27095.00 -96.76 877.50 27095.00 -96.76
Other Income 71.00 138.00 -48.55 1258.70 478.80 162.89 1258.70 478.80 162.89
PBIDT 55.10 689.70 -92.01 1190.90 4749.40 -74.93 1190.90 4749.40 -74.93
Interest 80.60 121.00 -33.39 305.90 1018.00 -69.95 305.90 1018.00 -69.95
PBDT -25.50 568.70 -104.48 885.00 3731.40 -76.28 885.00 3731.40 -76.28
Depreciation 15.90 110.00 -85.55 62.50 999.70 -93.75 62.50 999.70 -93.75
PBT -41.40 458.70 -109.03 822.50 2731.70 -69.89 822.50 2731.70 -69.89
TAX -10.30 107.10 -109.62 37.50 586.90 -93.61 37.50 586.90 -93.61
Deferred Tax -4.00 47.30 -108.46 -99.10 132.50 -174.79 -99.10 132.50 -174.79
PAT -31.10 351.60 -108.85 785.00 2144.80 -63.40 785.00 2144.80 -63.40
Equity 159.30 159.30 0.00 159.30 159.30 0.00 159.30 159.30 0.00
PBIDTM(%) 19.14 18.85 1.52 135.72 17.53 674.25 135.72 17.53 674.25
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..